Literature DB >> 1322694

Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids.

D Grobelny1, L Poncz, R E Galardy.   

Abstract

The hydroxamic acid HONHCOCH2CH(i-Bu)CO-L-Trp-NHMe, isomer 6A (GM 6001), inhibits human skin fibroblast collagenase with Ki of 0.4 nM using the synthetic thiol ester substrate Ac-Pro-Leu-Gly-SCH(i-Bu)CO-Leu-Gly-OEt at pH 6.5. The other isomer, 6B, which has the opposite configuration at the CH2CH(i-Bu)CO alpha-carbon atom, has a Ki of 200 nM for this enzyme. GM 6001 is one of the most potent inhibitors of human skin fibroblast collagenase yet reported. GM 6001 has a Ki of 20 nM against thermolysin and Pseudomonas aeruginosa elastase. Isomer 6B has a Ki of 7 nM against thermolysin and 2 nM against the elastase. 6A and 6B are the most potent hydroxamate inhibitors reported for these bacterial enzymes. The pattern of inhibition for all three enzymes suggests that isomer 6A is the (R,S) compound, stereochemically analogous to the L,L-dipeptide, and isomer 6B is the (S,S) compound, analogous to the DL-dipeptide. The tolerance of the D configuration by thermolysin and the elastase allows these inhibitors to discriminate between the human and bacterial enzymes simply by inversion of configuration at the CH2CH(i-Bu)CO alpha-carbon atom. Substitution of the potential metal liganding groups carboxylate and hydrazide for the hydroxamate group yields much weaker inhibitors for all three enzymes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322694     DOI: 10.1021/bi00146a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  84 in total

1.  Filamin A controls matrix metalloproteinase activity and regulates cell invasion in human fibrosarcoma cells.

Authors:  Massimiliano Baldassarre; Ziba Razinia; Nina N Brahme; Roberto Buccione; David A Calderwood
Journal:  J Cell Sci       Date:  2012-05-17       Impact factor: 5.285

2.  Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.

Authors:  Kunrong Cheng; Guofeng Xie; Jean-Pierre Raufman
Journal:  Biochem Pharmacol       Date:  2006-12-10       Impact factor: 5.858

3.  Rapid determination of enzyme kinetics from fluorescence: overcoming the inner filter effect.

Authors:  Mark O Palmier; Steven R Van Doren
Journal:  Anal Biochem       Date:  2007-07-18       Impact factor: 3.365

4.  Non-muscle myosin IIA differentially regulates intestinal epithelial cell restitution and matrix invasion.

Authors:  Brian A Babbin; Stefan Koch; Moshe Bachar; Mary-Anne Conti; Charles A Parkos; Robert S Adelstein; Asma Nusrat; Andrei I Ivanov
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

5.  Mechanisms of kringle fragment of urokinase-induced vascular smooth muscle cell migration.

Authors:  Elisa Roztocil; Suzanne M Nicholl; Mark G Davies
Journal:  J Surg Res       Date:  2007-07       Impact factor: 2.192

6.  The role of Delta-like 1 shedding in muscle cell self-renewal and differentiation.

Authors:  Danqiong Sun; Hui Li; Anna Zolkiewska
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

7.  Latanoprost-induced changes in rat intraocular pressure: direct or indirect?

Authors:  Shahid Husain; Phillip W Yates; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2008-08       Impact factor: 2.671

8.  Detection of in vivo matrix metalloproteinase activity using microdialysis sampling and liquid chromatography/mass spectrometry.

Authors:  Ying Wang; Dmitri V Zagorevski; Michelle R Lennartz; Daniel J Loegering; Julie A Stenken
Journal:  Anal Chem       Date:  2009-12-15       Impact factor: 6.986

9.  Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.

Authors:  Linda Chung; Deendayal Dinakarpandian; Naoto Yoshida; Janelle L Lauer-Fields; Gregg B Fields; Robert Visse; Hideaki Nagase
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

10.  Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease.

Authors:  A C Lau; T T Duong; S Ito; G J Wilson; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.